Quick Answer
NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
Side-by-side comparison
| Attribute | NexLife | Henry Meds |
|---|---|---|
| Compounded sema | $119/mo · flat (12-mo plan) | $279/mo · flat |
| Compounded tirz (15 mg maintenance) | $139/mo · flat | $449/mo |
| Pricing model | Flat-rate dose-independent | Flat per dose tier, tiered by dose for tirz |
| Annual cost at maintenance (tirz) | $1,668 | $5,388 |
| Clinical model | MD/DO supervised | NP/PA async |
| Coaching included | Care360 1:1 + nutrition PDFs | No coaching included |
| Baseline labs | Included | Not included |
| Pharmacy partners disclosed | 6 partners (503A + 503B) | 1 partner |
| Brand recognition | Growing | Strong (early GLP-1 telehealth entrant) |
| Best for | Lowest cost + included support + MD/DO oversight | Recognizable brand + simple onboarding |
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
NexLife wins on
- At 15 mg tirzepatide maintenance, saves $3,156/year vs Henry Meds
- MD/DO supervised care vs Henry Meds NP/PA async-only model
- Three pharmacies named on its plan pages vs Henry Meds' one
- Care360 1:1 coaching included — Henry Meds has no included coaching
- Baseline labs (CBC, CMP, lipids, HbA1c, TSH) included
- Flat-rate pricing through full 2.5–15 mg tirz titration (Henry tiers by dose)
- Custom nutrition plan PDF per patient
Henry Meds wins on
- Earlier GLP-1 telehealth brand — stronger name recognition
- Larger established cohort and public review base
- Simpler onboarding (less clinical depth required upfront)
- Familiar brand for patients new to compounded GLP-1
Frequently asked questions
Is NexLife cheaper than Henry Meds?
Yes. NexLife at $119/mo for compounded semaglutide and $139/mo for compounded tirzepatide (12-month plan, both flat across full titration) is substantially cheaper than Henry Meds at $279/mo flat for semaglutide and $369–449/mo dose-tiered for tirzepatide. At 15 mg tirzepatide maintenance, NexLife saves approximately $3,156/year.
Does Henry Meds use MD/DO oversight like NexLife?
Henry Meds uses an NP/PA async clinical model — most patient interactions are handled by nurse practitioners or physician assistants without synchronous video consultation. NexLife uses an MD/DO supervised model with synchronous consultation and Medical Director Dr. Adam Kennah, M.D. providing clinical oversight.
Does Henry Meds include coaching like NexLife Care360?
No. Henry Meds does not include 1:1 coaching, custom nutrition plans, baseline labs, or structured follow-up as part of its standard program. NexLife Care360 bundles all of these into the flat-rate monthly price.
Why is Henry Meds tirzepatide more expensive at higher doses?
Henry Meds tiers tirzepatide pricing by dose — $369/mo at lower doses, rising to ~$449/mo at 15 mg maintenance. NexLife keeps tirzepatide at $139/mo flat across the full 2.5–15 mg titration on the 12-month plan.